S100A8 as potential salivary biomarker of oral squamous cell carcinoma using nanoLC-MS/MS

Clinica Chimica Acta

Volumn 436, Issue , 2014, Pages 121-129

  Jou, Yu Jen ^a,b   Hua, Chun Hung ^c   Lin, Chia Der ^c   Lai, Chih Ho ^d   Huang, Su Hua ^e   Tsai, Ming Hsui ^c   Kao, Jung Yie ^b   Lin, Cheng Wen ^a,e  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e ASIA UNIVERSITY   (Taiwan)

Author keywords

Biomarker; LC MS MS; Oral squamous cell carcinoma; S100A8; Saliva

Indexed keywords

CALGRANULIN A; GAMMA G GLOBIN; GLOBIN; HEMOGLOBIN D; PSORIASIN; UNCLASSIFIED DRUG; S100 PROTEINS; S100A7 PROTEIN, HUMAN; TUMOR MARKERS, BIOLOGICAL;

ADULT; ARTICLE; AUTOMATED NANO LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SALIVA; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TUMOR VOLUME; WESTERN BLOTTING; AMINO ACID SEQUENCE; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHEMISTRY; CHROMATOGRAPHY, LIQUID; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; METABOLISM; MIDDLE AGED; MOUTH NEOPLASMS; NANOTECHNOLOGY; PROTEOMICS; ROC CURVE;

AMINO ACID SEQUENCE; CALGRANULIN A; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NANOTECHNOLOGY; PROTEOMICS; ROC CURVE; S100 PROTEINS; SALIVA; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL;

EID: 84901844768     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.05.009     Document Type: Article

References (48)

1. Greenlee R.T., Murray T., Bolden S., Phyllis A. Cancer statistics, 2000. CA Cancer J Clin 2000, 50:7-33.
2. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
3. Cancer facts and figures 2006 2006, American Cancer Society, Atlanta.
4. Ho P.S., Yang Y.H., Shieh Y.T., et al. Consumption of areca quid, cigarettes, and alcohol related to the comorbidity of oral submucous fibrosis and oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007, 104:647-652.
5. Zhang X., Reichart P.A. A review of betel quid chewing, oral cancer and precancer in Mainland China. Oral Oncol 2007, 43:424-430.
6. Haughey B.H., Gates G.A., Arfken C.L., Harvey J. Meta-analysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol. Ann Otol Rhinol Laryngol 1992, 101:105-112.
7. Jones A.S., Morar P., Phillips D.E., Field J.K., Husband D., Helliwell T.R. Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer 1995, 75:1343-1353.
8. Jovanovic A., van der Toll G., Kostense J.P., et al. Second respiratory and upper digestive tract cancer following oral squamous cell carcinoma. Eur J Cancer B Oral Oncol 1994, 30B:225-229.
9. Tepperman B.S., Fitzpatrick P.J. Second respiratory and upper digestive tract cancers after oral cancer. Lancet 1981, 2:547-549.
10. Tsantoulis P.K., Kastrinakis N.G., Tourvas A.D., Laskaris G., Gorgoulis V.G. Advances in the biology of oral cancer. Oral Oncol 2007, 43:523-534.
11. Canto M.T., Devesa S.S. Oral cavity and pharynx cancer incidence rates in the United States, 1975-1998. Oral Oncol 2002, 38:610-617.
12. Silverman S.J. Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Am Dent Assoc 2001, 132:7S-11S.
13. Yen C.Y., Huang C.Y., Hou M.F., et al. Evaluating the performance of fibronectin 1 (FN1), integrin α4β1 (ITGA4), syndecan-2 (SDC2), and glycoprotein CD44 as the potential biomarkers of oral squamous cell carcinoma (OSCC). Biomarkers 2013, 63-72.
14. Yen C.Y., Chen C.H., Chang C.H., et al. Matrix metalloproteinases (MMP) 1 and MMP10 but not MMP12 are potential oral cancer markers. Biomarkers 2009, 14:244-249.
15. Hsieh H.L., Schäfer B.W., Sasaki N., Heizmann C.W. Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays. Biochem Biophys Res Commun 2003, 307:375-381.
16. Salama I., Malone P.S., Mihaimeed F., Jones J.L. A review of the S100 proteins in cancer. EJSO 2008, 34:357-364.
17. Kriajevska M., Tarabykina S., Bronstein I., et al. Metastasis-associated Mts1 (S100A4) protein modulates protein kinase C phosphorylation of the heavy chain of nonmuscle myosin. J Biol Chem 1998, 273:9852-9856.
18. Murakami N., Kotula L., Hwang Y.W. Two distinct mechanisms for regulation of nonmuscle myosin assembly via the heavy chain: phosphorylation for MIIB and mts 1 binding for MIIA. Biochemistry 2000, 39:11441-11451.
19. Rudland P.S., Platt-Higgins A., Renshaw C., et al. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res 2000, 60:1595-1603.
20. Sneh A., Deol Y.S., Ganju A., et al. Differential role of psoriasin (S100A7) in estrogen receptor α positive and negative breast cancer cells occur through actin remodeling. Breast Cancer Res Treat 2013, 138:727-739.
21. Odink K., Cerletti N., Brüggen J., et al. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 1987, 330:80-82.
22. Roth J., Teigelkamp S., Wilke M., Grün L., Tümmler B., Sorg C. Complex pattern of the myelo-monocytic differentiation antigens MRP8 and MRP14 during chronic airway inflammation. Immunobiology 1992, 186:304-314.
23. van Lent P.L., Grevers L.C., Blom A.B., et al. Stimulation of chondrocyte-mediated cartilage destruction by S100A8 in experimental murine arthritis. Arthritis Rheum 2008, 58:3776-3787.
24. Youssef P., Roth J., Frosch M., et al. Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane. J Rheumatol 1999, 26:2523-2528.
25. Koon N., Zaika A., Moskaluk C.A., et al. Clustering of molecular alterations in gastroesophageal carcinomas. Neoplasia 2004, 6:143-149.
26. Sy S.M., Wong N., Lai P.B., To K.F., Johnson P.J. Regional over-representations on chromosomes 1q, 3q and 7q in the progression of hepatitis B virus-related hepatocellular carcinoma. Mod Pathol 2005, 18:686-692.
27. Moinzadeh P., Breuhahn K., Stützer H., Schirmacher P. Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade-results of an explorative CGH meta-analysis. Br J Cancer 2005, 92:935-941.
28. Grigorian M., Andresen S., Tulchinsky E., et al. Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction. J Biol Chem 2001, 276:22699-22708.
29. Lin J., Blake M., Tang C., et al. Inhibition of p53 transcriptional activity by the S100B calcium-binding protein. J Biol Chem 2001, 276:35037-35041.
30. Jou Y.J., Lin C.D., Lai C.H., et al. Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer. Anal Chim Acta 2010, 681:41-48.
31. Driemel O., Escher N., Ernst G., Melle C., von Eggeling F. S100A8 cellular distribution in normal epithelium, hyperplasia, dysplasia and squamous cell carcinoma and its concentration in serum. Anal Quant Cytol Histol 2010, 32:219-224.
32. Kesting M.R., Sudhoff H., Hasler R.J., et al. Psoriasin (S100A7) up-regulation in oral squamous cell carcinoma and its relation to clinicopathologic features. Oral Oncol 2009, 45:731-736.
33. Sapkota D., Bruland O., Bøe O.E., et al. Expression profile of the S100 gene family members in oral squamous cell carcinomas. J Oral Pathol Med 2008, 37:607-615.
34. Jou Y.J., Lin C.D., Lai C.H., et al. Salivary zinc finger protein 510 peptide as a novel biomarker for detection of oral squamous cell carcinoma in early stages. Clin Chim Acta 2011, 412:1357-1365.
35. Sobin L.H., Wittekind C.H. TNM classification of malignant tumors 2002, Wiley, New York.
36. Li Y., Wen T., Zhu M., et al. Glycoproteomic analysis of tissues from patients with colon cancer using lectin microarrays and nanoLC-MS/MS. Mol Biosyst 2013, 9:1877-1887.
37. Schaaij-Visser T.B., de Wit M., Lam S.W., Jiménez C.R. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context. Biochim Biophys Acta 1834, 2013:2242-2258.
38. Opstal-van Winden A.W., Krop E.J., Kåredal M.H., et al. Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control study. BMC Cancer 2011, 11:381.
39. 18O labeling and nanoLC-MS/MS coupled with laser capture microdissection. Med Oncol 2010, 27:296-303.
40. Grebhardt S., Müller-Decker K., Bestvater F., Hershfinkel M., Mayer D. Impact of S100A8/A9 expression on prostate cancer progression in vitro and in vivo. J Cell Physiol 2013, 10.1002/jcp.24489.
41. Parris T.Z., Kovács A., Aziz L., et al. Additive effect of the AZGP1, PIP, S100A8, and UBE2C molecular biomarkers improves outcome prediction in breast carcinoma. Int J Cancer 2013, 10.1002/ijc.28497.
42. Skaggs H.S., Saunders B.A., Miller R.W., et al. Ovarian cyst fluids are a cache of tumor biomarkers that include calgranulin A and calgranulin B isoforms. Cancer Invest 2013, 31:433-453.
43. Kim H.J., Kang H.J., Lee H., et al. Identification of S100A8 and S100A9 as serological markers for colorectal cancer. J Proteome Res 2008, 8:1368-1379.
44. Wang L., Chang E.W., Wong S.C., Ong S.M., Chong D.Q., Ling K.L. Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8/A9 proinflammatory proteins. J Immunol 2013, 190:794-804.
45. Kaur J., Matta A., Kak I., et al. S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia. Int J Cancer 2013, 10.1002/ijc.28473.
46. Liu H., Wang L., Wang X., Cao Z., Yang Q., Zhang K. S100A7 enhances invasion of human breast cancer MDA-MB-468 cells through activation of nuclear factor-κB signaling. World J Surg Oncol 2013, 11:93.
47. Ye L., Sun P.H., Martin T.A., Sanders A.J., Mason M.D., Jiang W.G. Psoriasin (S100A7) is a positive regulator of survival and invasion of prostate cancer cells. Urol Oncol 2013, 31:1576-1583.
48. Emara M., Turner A.R., Allalunis-Turner J. Adult, embryonic and fetal hemoglobin are expressed in human glioblastoma cells. Int J Oncol 2013, 10.3892/ijo.2013.2186.